azoxymethane has been researched along with cannabidiol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aviello, G; Borrelli, F; Capasso, R; Di Marzo, V; Gallo, L; Izzo, AA; Piscitelli, F; Romano, B | 1 |
| Borrelli, F; Cascio, MG; Izzo, AA; Pagano, E; Pertwee, RG; Romano, B | 1 |
2 other study(ies) available for azoxymethane and cannabidiol
| Article | Year |
|---|---|
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Caco-2 Cells; Cannabidiol; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Comet Assay; HCT116 Cells; Humans; Male; Mice; Mice, Inbred ICR | 2012 |
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
Topics: Animals; Azoxymethane; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabis; Carcinogenesis; Carcinoma; Cell Proliferation; Cell Survival; CHO Cells; Colonic Neoplasms; Cricetinae; Cricetulus; Epithelial Cells; HCT116 Cells; Humans; Male; Mice, Inbred ICR; Phytotherapy; Plant Extracts; Random Allocation; Receptors, Cannabinoid; Xenograft Model Antitumor Assays | 2014 |